Mavacamten Recruiting Phase 2 Trials for Heart Failure With Preserved Ejection Fraction (HFpEF) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04766892A Study of Mavacamten in Participants With HFpEF and Chronic Elevation of cTnI and/or NT-proBNP